These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Role of immunmodulators in allergen-specific immunotherapy. Kopp MV Allergy; 2011 Jun; 66(6):792-7. PubMed ID: 21332502 [TBL] [Abstract][Full Text] [Related]
7. Treatment with a combination of anti-IgE and specific immunotherapy for allergic rhinitis and asthma. Hamelmann E; Rolinck-Werninghaus C; Wahn U; Kopp MV Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():303-13; discussion 313-5. PubMed ID: 20799475 [TBL] [Abstract][Full Text] [Related]
8. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation. Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125 [TBL] [Abstract][Full Text] [Related]
9. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy. Pipet A; Botturi K; Pinot D; Vervloet D; Magnan A Respir Med; 2009 Jun; 103(6):800-12. PubMed ID: 19216064 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of allergen specific immunotherapy--T-cell tolerance and more. Jutel M; Akdis M; Blaser K; Akdis CA Allergy; 2006 Jul; 61(7):796-807. PubMed ID: 16792576 [TBL] [Abstract][Full Text] [Related]
11. Sublingual immunotherapy: an update on immunologic and functional effects. Ciprandi G; Fenoglio D; Cirillo I; Tosca MA; La Rosa M; Licari A; Marseglia A; Barberi S; Marseglia GL Allergy Asthma Proc; 2007; 28(1):40-3. PubMed ID: 17390756 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data. Ariano R; Panzani RC; Mistrello G Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):103-8. PubMed ID: 15918297 [TBL] [Abstract][Full Text] [Related]
14. Baseline serum tryptase levels and adverse reactions to injection specific immunotherapy with airborne allergens: is there a relationship? Asero R; Farioli L; Pastorello EA Int Arch Allergy Immunol; 2012; 158(3):276-80. PubMed ID: 22398453 [TBL] [Abstract][Full Text] [Related]
15. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study. Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of allergen-specific immunotherapy and novel ways for vaccine development. Jutel M; Van de Veen W; Agache I; Azkur KA; Akdis M; Akdis CA Allergol Int; 2013 Dec; 62(4):425-33. PubMed ID: 24153333 [TBL] [Abstract][Full Text] [Related]
20. Immune mechanisms of allergen-specific sublingual immunotherapy. Moingeon P; Batard T; Fadel R; Frati F; Sieber J; Van Overtvelt L Allergy; 2006 Feb; 61(2):151-65. PubMed ID: 16409190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]